Literature DB >> 8457573

Interaction of the 47-residue antibacterial peptide seminalplasmin and its 13-residue fragment which has antibacterial and hemolytic activities with model membranes.

N Sitaram1, R Nagaraj.   

Abstract

The interaction of seminalplasmin (SPLN), a 47-residue antibacterial peptide, and its 13-residue fragment (SPF), which has antibacterial and hemolytic activities, with model membranes has been investigated. The fluorescence characteristics of the single Trp residue in these peptides indicate strong binding to lipid vesicles. SPLN binds more strongly to dioleoylphosphatidylglycerol vesicles compared to dioleoylphosphatidylcholine and phosphatidylserine vesicles. Localization studies using fluorescence quenchers like NO3-, I-, and acrylamide indicate that the Trp residues in both of the peptides are located away from the head group region and are associated with the hydrophobic core. Both peptides cause release of carboxyfluorescein from zwitterionic as well as anionic vesicles. The biological activities of SPLN and SPF have been rationalized in terms of lipid-peptide interactions. It is proposed that the specificity in biological activity arises due to differences in the manner in which the peptides associate with the bacterial and red blood cell surfaces.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457573     DOI: 10.1021/bi00063a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Biophysical studies of the interactions between the phage varphiKZ gp144 lytic transglycosylase and model membranes.

Authors:  Isabelle Cloutier; Catherine Paradis-Bleau; Anne-Marie Giroux; Xavier Pigeon; Marjolaine Arseneault; Roger C Levesque; Michèle Auger
Journal:  Eur Biophys J       Date:  2009-08-08       Impact factor: 1.733

2.  Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract.

Authors:  E S Lysenko; J Gould; R Bals; J M Wilson; J N Weiser
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.

Authors:  K S Satheeshkumar; R Jayakumar
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.